Clinical Trial Update: Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Shenlingcao Oral Liquid for patients with stage II/IIIa non-small cell lung cancer following chemotherapy. The study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Shenlingcao Oral Liquid

Snippet

Sponsor: West China Hospital | Conditions: Carcinoma, Non-Small-Cell Lung, Chemotherapy, Adjuvant | Phase 4 | Status: COMPLETED